Marshall Wace
MYOK

Marshall Wace’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Marshall Wace’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-142,028
Closed -$13.7M – 2086
2020
Q2 		$13.7M Buy
+142,028
New +$11.8M 0.1% 221
2020
Q1 		– Sell
-30,073
Closed -$2.19M – 2256
2019
Q4 		$2.19M Sell
30,073
-64,041
-68% -$3.88M 0.02% 783
2019
Q3 		$4.91M Sell
94,114
-85,946
-48% -$4.57M 0.04% 512
2019
Q2 		$9.03M Sell
180,060
-275,359
-60% -$13.4M 0.07% 311
2019
Q1 		$23.7M Buy
+455,419
New +$21M 0.22% 90
2017
Q1 		– Sell
-121,304
Closed -$1.57M – 874
2016
Q4 		$1.57M Buy
121,304
+21,304
+21% +$328K 0.01% 685
2016
Q3 		$1.63M Buy
+100,000
New +$1.81M 0.01% 641

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return